Shorted

Victory Metals (VTM) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
just now

Why Victory Metals (ASX:VTM) Is Back on the Radar for Small-Cap Stocks?

Highlights Victory Metals sits at the intersection of broader Australian market signals and commercial milestones. Demand composition, not just demand direction, matters for understanding the company story. Execution across market access, costs and capital allocation can separate company performance from sector momentum. A broad market headline can hide very different company realities. For Victory Metals (ASX:VTM), the more useful reading starts with commercial milestones, then moves through...

Continue reading
Kalkine
Neutral
just now

Victory Metals (ASX:VTM) Ships Heavy Rare Earth Samples Offshore

Highlights Heavy rare earth concentrate from a Western Australian clay deposit has been dispatched for independent examination by prospective partners. Pilot plant operation is delivering enriched concentrate under continuous conditions. Offtake validation is emerging as the decisive milestone for the next tier of Australian projects. Victory Metals (ASX:VTM), developer of the North Stanmore clay-hosted heavy rare earth project near Cue in Western Australia, has dispatched concentrate samples t...

Continue reading
Kalkine
Neutral
just now

Can Victory Metals (ASX:VTM) Turn Sample Shipments Into Rare Earth Offtake Deals?

Highlights Victory Metals has shipped heavy rare earth concentrate from its Western Australian project to prospective partners for independent testing. Pilot plant operations continue producing enriched concentrate under continuous operating conditions. Product validation and future offtake discussions are becoming the next major milestones for Australia's emerging rare earth developers. Victory Metals Ltd (ASX:VTM) has taken another step towards commercial development by dispatching heavy rare...

Continue reading
Kalkine
Neutral
just now

Victory Metals (VTM) Lists 200,000 New Shares After Performance Rights Conversion on ASX

Victory Metals Limited has announced the listing of 200,000 additional ordinary shares on the Australian Securities Exchange (ASX) following the conversion of performance rights. This milestone marks a key achievement in the company’s capital management strategy and may enhance the liquidity of Victory Metals’ shares for investors. Key Points Victory Metals Limited (VTM) Listing of 200,000 additional ordinary shares on ASX Performance rights converted without cash consideration Investors ...

Continue reading
Kalkine
Neutral
just now

Victory Metals Limited Issues 200,000 Shares Under Corporations Act Section 708A(5) Exemption

Victory Metals Limited has issued 200,000 fully paid ordinary shares utilizing the exemption under section 708A(5) of the Corporations Act 2001. This provision enables the company to issue shares without a disclosure document, a point of interest for investors tracking regulatory compliance and corporate governance. Victory Metals confirmed its adherence to all relevant legislative requirements, ensuring transparency in its corporate activities. Key Points Victory Metals Limited (ASX: VTM) Is...

Continue reading
Kalkine
Neutral
just now

Victory Metals (ASX:VTM) Advances North Stanmore After Securing Traditional Owner Agreement

Highlights Victory Metals (ASX:VTM) has secured a key agreement with the Wajarri Yamaji Aboriginal Corporation for the North Stanmore project. The agreement provides traditional owner consent and land access arrangements, supporting the mining licence pathway. Progress continues on the North Stanmore pre-feasibility study as the project advances toward development. Victory Metals (ASX:VTM) has achieved a significant milestone for its North Stanmore heavy rare earths project in Western Austral...

Continue reading
Kalkine
Neutral
just now

Why Mayne Pharma’s Court Victory Is Turning Heads

Highlights Mayne Pharma secures a major court costs order in ongoing legal proceedings. Legal outcomes are becoming increasingly important across the healthcare sector. Pharmaceutical companies continue navigating regulation, litigation and product expansion. ASX stock market continues to closely monitor healthcare and pharmaceutical companies as regulatory developments and legal proceedings reshape sentiment across the sector. Mayne Pharma Group Limited (ASX:MYX), an Australian special...

Continue reading